Network·Hedge Fund
📍 WASHINGTON, DC
SEC CRD #802-78542
Portfolio Portfolio Team News Built by the bold, backed by Revolution Explore our portfolio Close Company HQ: Chicago , Illinois Making Precision Medicine a Reality Their Vision Tempus was founded with a bold goal: bring AI to clinical care at scale. After dealing with the limitations of the existing system during his wife’s battle with breast cancer, serial entrepreneur Eric Lefkofsky began building the team, platform, and partnerships to amass one of the largest libraries of clinical and genomic data in the world and make precision medicine a reality for more people. Our Conviction We were confident in the market opportunity (healthcare, after all, is one of the largest and most ripe-for-disruption sectors) and drawn to Tempus’s mission to make sure each patient receives the right treatment to live a longer and healthier life. We were also confident that Eric and his team had the track record and technical depth to turn that mission into a platform physicians, hospitals, and pharmaceutical companies could trust. From Series C to IPO, we supported the company’s progress with key introductions and board development as it grew from 50 employees to thousands, expanded into new disease areas, and proved what a virtuous cycle of research, data, and machine learning could achieve in healthcare. Milestones 2015: Eric Lefkofsky founds Tempus 2017: Receives first investment from Revolution Growth (Series C) 2020: Expands platform beyond oncology into neuropsychiatry, cardiology, in
KERRY L. KILLEEN
CHIEF COMPLIANCE OFFICER
📞 (202) 776-1400
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Location
WASHINGTON, DC
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.